Washington, D.C. (Sept. 22, 2015)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, sent a letter to Chairman Jason Chaffetz requesting that the Committee hold a hearing with Martin Shkreli, the 32-year-old former hedge fund manager whose company recently purchased the life-saving drug Daraprim and increased the price from $13.50 to $750 per pill “overnight.” In responding to a virtually instant outcry of criticism, Mr. Shkreli tweeted that his price increase is “a great thing for society.”  He also berated a reporter as a “moron” for requesting an explanation for his indefensible...